Home Cart 0 Sign in  

[ CAS No. 1191951-57-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1191951-57-1
Chemical Structure| 1191951-57-1
Structure of 1191951-57-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1191951-57-1 ]

Related Doc. of [ 1191951-57-1 ]

Alternatived Products of [ 1191951-57-1 ]

Product Details of [ 1191951-57-1 ]

CAS No. :1191951-57-1 MDL No. :MFCD18384970
Formula : C20H31N3O2S2 Boiling Point : -
Linear Structure Formula :- InChI Key :BYWWNRBKPCPJMG-UHFFFAOYSA-N
M.W : 409.61 Pubchem ID :44240850
Synonyms :
Akt Inhibitor XIV;CS-0223
Chemical Name :4-Dodecyl-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide

Calculated chemistry of [ 1191951-57-1 ]

Physicochemical Properties

Num. heavy atoms : 27
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.6
Num. rotatable bonds : 14
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 114.87
TPSA : 108.57 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -3.52 cm/s

Lipophilicity

Log Po/w (iLOGP) : 4.29
Log Po/w (XLOGP3) : 7.44
Log Po/w (WLOGP) : 6.69
Log Po/w (MLOGP) : 2.95
Log Po/w (SILICOS-IT) : 5.78
Consensus Log Po/w : 5.43

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -6.44
Solubility : 0.000147 mg/ml ; 0.00000036 mol/l
Class : Poorly soluble
Log S (Ali) : -9.55
Solubility : 0.000000115 mg/ml ; 0.0000000003 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -8.17
Solubility : 0.00000278 mg/ml ; 0.0000000068 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 3.97

Safety of [ 1191951-57-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H320-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1191951-57-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1191951-57-1 ]
  • Downstream synthetic route of [ 1191951-57-1 ]

[ 1191951-57-1 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 4005-51-0 ]
  • [ 52499-14-6 ]
  • [ 1191951-57-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 6, p. 2046 - 2054
[2] Patent: WO2009/129267, 2009, A2, . Location in patent: Page/Page column 85
  • 2
  • [ 123-01-3 ]
  • [ 1191951-57-1 ]
Reference: [1] Patent: WO2009/129267, 2009, A2,
  • 3
  • [ 14564-74-0 ]
  • [ 1191951-57-1 ]
Reference: [1] Patent: WO2009/129267, 2009, A2,
Same Skeleton Products
Historical Records